Endo, Inc (OTCQX: NDOI) (“Endo”), announced today that one of its operating subsidiaries, Endo USA, Inc., is voluntarily recalling all lots within expiry of Adrenalin® Chloride Solution (EPINEPHrine ...
Please provide your email address to receive an email when new articles are posted on . The FDA has advised health care professionals that they should not use unapproved epinephrine nasal solutions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results